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Background—The mechanisms of increased neointimal hyperplasia after coronary interventions in diabetic patients are
still unknown.
Methods and Results—Glucose and insulin effects on in vitro vascular smooth muscle cell (VSMC) proliferation and
migration were assessed. The effect of balloon injury on neointimal hyperplasia was studied in streptozotocin-induced
diabetic rats with or without adjunct insulin therapy. To study the effect of balloon injury in nondiabetic rats with
hyperinsulinemia, pancreatic islets were transplanted under the kidney capsule in normal rats. Glucose did not increase
VSMC proliferation and migration in vitro. In contrast, insulin induced a significant increase in VSMC proliferation and
migration in cell cultures. Furthermore, in VSMC culture, insulin increased MAPK activation. A reduction in neointimal
hyperplasia was consistently documented after vascular injury in hyperglycemic streptozotocin-induced diabetic rats.
Insulin therapy significantly increased neointimal hyperplasia in these rats. This effect of hyperinsulinemia was totally
abolished by transfection on the arterial wall of the N17H-ras–negative mutant gene. Finally, after experimental balloon
angioplasty in hyperinsulinemic nondiabetic islet-transplanted rats, a significant increase in neointimal hyperplasia was
observed.
Conclusions—In rats with streptozotocin-induced diabetes, balloon injury was not associated with an increase in
neointimal formation. Exogenous insulin administration in diabetic rats and islet transplantation in nondiabetic rats
increased both blood insulin levels and neointimal hyperplasia after balloon injury. Hyperinsulinemia through activation
of the ras/MAPK pathway, rather than hyperglycemia per se, seems to be of crucial importance in determining the
exaggerated neointimal hyperplasia after balloon angioplasty in diabetic animals. (Circulation. 2001;103:2980-2986.)
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Diabetes mellitus is a poor prognostic factor for allpatients with coronary artery disease and specifically for
those who undergo CABG or balloon angioplasty.1–3 It is also
well recognized that restenosis rates may be very high,
varying from 49% to 71% among diabetic patients.1–5
In addition, patients with diabetes mellitus and multivessel
coronary disease were found to have a significantly higher
mortality rate with PTCA than with CABG.1–6
Extensive data are not yet available on coronary stents in
patients with diabetes, but the use of internal mammary
arteries with bypass grafting seems to be preferred, especially
in patients with multivessel disease.7–9
Serial intravascular ultrasound analysis showed that the
main mechanism for increased restenosis in diabetic patients
was an exaggerated intimal hyperplasia both in the presence
and in the absence of stent deployment.10 In addition, the
molecular mechanisms underlying this exaggerated vascular
smooth muscle cell (VSMC) proliferation and the relative
role of hyperglycemia versus hyperinsulinemia in promoting
a greater restenosis after angioplasty or stenting have not yet
been investigated.
Therefore, the aims of the present study were to assess
(1) the effects of glucose and insulin on VSMC proliferation
and migration in vitro, (2) response to balloon injury in rats
with streptozotocin (STZ)-induced diabetes with or without
adjunct insulin therapy, and (3) neointimal hyperplasia after
vascular injury in nondiabetic rats with hyperinsulinemia
after pancreatic islet transplantation.
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Methods
VSMC Proliferation In Vitro
To assess the effects of glucose and insulin, 29.53104 VSMCs (A10,
thoracic rat aorta) were plated and grown in DMEM/10% FCS in the
presence of low (5.6 mmol/L), medium (14 mmol/L), and high
(22.2 mmol/L) glucose or in the presence of different insulin
concentrations (2, 20, and 200 nmol/L) or in the absence of the same
(control). To evaluate glucose osmotic effects on VSMC prolifera-
tion, we included an additional control with an osmotically active
nonmetabolized agent, sorbitol, at the same glucose concentrations.
Cell numbers in all conditions were assessed every 48 hours for 6
days.
Mitogen-Activated Protein Kinase Assay
To assess the effect of insulin on the activation of the ras/MAPKK
pathway, VSMCs were starved in DMEM/0.5% FCS for 48 hours.
Then they were stimulated by different concentrations of insulin (2,
20, and 200 nmol/L) for 10 minutes. After this time, VSMCs were
processed for mitogen-activated protein kinase (MAPK) assay, as
previously described.11
VSMC Migration Assay
VSMC migration was assayed by a modification of the Boyden’s
chamber method as previously described.12 VSMCs (203103) were
placed in the upper chamber, and 25 mL of serum-free medium
containing a migration factor such as N-formyl-methionyl-leucyl-
phenylalanine (FMLP) or insulin or glucose was placed in the lower
chamber. At the end of the assay period, VSMCs that had migrated
to the lower side of the filter were counted under a microscope
(3100) to quantify VSMC migration. Migration activity was ex-
pressed as the mean number of cells that had migrated per high-
power field.
Animal Model of Diabetes
Animals in this study were handled according to the animal welfare
regulation of Federico II University of Naples, and the protocol was
approved by the animal use committee of this institution in accor-
dance with the animal use principles of the American Society of
Physiology.
Fifty Wistar rats (Charles River, Calco, Italy) were treated at 14
weeks of age with a single intraperitoneal injection of 100 mg/kg
STZ (Sigma) in 0.05 mol/L citrate buffer. This model resembles
insulin-dependent diabetes mellitus (IDDM) as previously
described.13
The diabetic state was assessed starting the day after STZ injection
by measurements of nonfasting plasma glucose concentration with a
portable glucose meter (One Touch II; Johnson & Johnson). Only
animals with plasma glucose concentrations .300 mg/dL were
considered diabetics and were included in the present study.
Rat Islet Isolation and Transplantation
To obtain a rat model of hyperinsulinemia without diabetes, in 14
Fisher rats (Charles River, Calco, Italy) at 10 weeks after birth,
pancreatic islets were transplanted under the kidney capsule by 1
investigator (A.D.) as previously described.14
Experimental Angioplasty Technique
Angioplasty of the carotid artery was performed as previously
described and validated in our laboratory.15–18
Study Design
Protocol I
The animals with STZ-induced diabetes were randomized before
balloon injury into 2 groups: STZ group (n511) and STZ1INS
group (n511, with insulin therapy).
Protocol II
Balloon injury was performed at 14 weeks after birth in hyperinsu-
linemic nondiabetic rats after islet transplantation (Transp Hyperins
group).
Protocol III
In 12 rats with STZ-induced diabetes treated with insulin, we
evaluated the effects of the in vivo inhibition of cellular ras using a
negative mutant gene (N17H-ras) at the moment of the balloon
injury (STZ/INS/ras group) as previously described.16
Insulin Administration
In the STZ1INS and in STZ/INS/ras groups, the day after STZ
injection and for the following 14 days, insulin (Monotard, Novo
Nordisk) was administered twice a day, from 4 to 8 IU according to
plasma glucose level determined every day by use of the One Touch
system. Balloon injury was performed 48 hours after STZ in the
STZ1INS and STZ/INS/ras groups; thus, insulin was administered
for a total of 16 days in both groups.
Blood Glucose and Insulin Levels
Blood samples from the tail vein were taken at the time of balloon
injury and when carotid arteries were removed. These samples were
analyzed for levels of glycemia and insulinemia. Plasma glucose was
determined with the One Touch system. Insulin concentration was
determined with a double-antibody radioimmunoassay using guinea
pig anti-rat insulin serum, a rat insulin standard, and 125I-labeled
insulin (Linco Research).
Statistical Analysis
All data are shown as mean6SEM. Statistical analysis between
groups was performed by 1-way ANOVA with an SPSS 10.0
program. When a significant overall effect was detected, Tukey’s test
was applied to compare single mean values. A value of P,0.05 was
considered significant.
Results
Effects of Glucose and Insulin on VSMC
Proliferation In Vitro
Figure 1a shows that high glucose concentration markedly
inhibited VSMC proliferation. We observed similar results in
an additional control with an osmotically active nonmetabo-
lized agent, sorbitol, at the same glucose concentrations
(Figure 1b). In contrast, insulin increased VSMC prolifera-
tion in a dose-dependent manner (Figure 2a).
Effects of Insulin on the Activation of the
ras/MAPK Pathway
Insulin increased ras/MAPK activation, as demonstrated by
the increase in extracellular signal–regulated kinase (ERK)
activation at all insulin concentrations (Figure 2b). Only at
nonphysiological concentration did insulin weakly activate
c-Jun NH2-terminal kinase (JNK) and produce an evident
increase of P38 activation (Figure 2b). These data suggest
that ERK downstream ras is the principal intracellular target
of the action of insulin on VSMCs.
Effects of Glucose and Insulin on VSMC
Migration In Vitro
Figure 3 shows that insulin significantly increased VSMC
migration in a dose-dependent manner (Figure 3a). In contrast,
cultured VSMCs were unaffected by glucose (Figure 3b).
Indolfi et al Neointimal Hyperplasia in Hyperinsulinemic Rats 2981
 by guest on N
ovem
ber 11, 2016
http://circ.ahajournals.org/
D
ow
nloaded from
 
Effects of Vascular Injury on Neointimal
Hyperplasia in Rats With STZ-Induced Diabetes
(Protocol I)
After STZ injection, a 30% mortality was observed. A
reproducible neointimal formation was found 14 days after
balloon injury in the control group (CON group, n512;
neointima 0.11360.026 mm2; neointima/media ratio
1.12360.229) (Figures 4 and 5). Surprisingly, in animals
treated with STZ (STZ group, n59), we observed a signifi-
cant reduction of both neointimal area and neointima/media
ratio (neointima 0.07060.029 mm2, P,0.001 versus CON;
neointima/media ratio 0.50860.201, P,0.001 versus CON)
(Figures 4 and 5). After balloon injury, we had a 20%
mortality in rats of the control group and in rats with
STZ-induced diabetes.
Effect of Vascular Injury on Neointimal
Hyperplasia in STZ-Induced Diabetic Rats With
Insulin Therapy (Protocol I)
After balloon injury in animals with insulin-treated STZ-
induced diabetes (STZ1INS group, n59), we observed a
significant increase of both neointimal area and neointima/
media ratio (neointima 0.21760.036 mm2, P,0.001 versus
CON; neointima/media ratio 1.72260.364, P,0.001 versus
CON) (Figures 4 and 5).
Effect of Islet Transplantation on Neointimal
Hyperplasia After Vascular Injury (Protocol II)
In nondiabetic animals with hyperinsulinemia after islet
transplantation (Transp Hyperins, n55), we detected a sig-
nificant increase of both neointimal area and neointima/media
ratio after balloon injury (neointima 0.14760.009 mm2,
P,0.05 versus CON; neointima/media ratio 1.54560.082,
P,0.001 versus CON) (Figures 4 and 5). In these animals, a
30% mortality after balloon injury was observed.
Effect of ras Inhibition on Neointimal Hyperplasia
After Vascular Injury in Rats With STZ-Induced
Diabetes (Protocol III)
In an additional 12 rats with STZ-induced diabetes under
insulin therapy, the transfection on the vascular wall of a
ras-negative mutant gene (N17H-ras) at the moment of the
balloon injury (STZ/INS/ras group, n59) caused a significant
reduction of both neointimal area and neointima/media ratio
compared with both the CON and the STZ1INS groups
(neointima 0.06960.018 mm2, P,0.001 versus CON and
STZ1INS; neointima/media ratio 0.53960.114, P,0.001
versus CON and STZ1INS) (Figures 4 and 5).
Blood Glucose and Insulin Levels
Control rats (CON group) had a glycemia of 144619.3
mg/dL and an insulinemia of 67.268.6 mU/mL (Figure 6).
Figure 1. a, Effects of low (5.6 mmol/L), medium (14 mmol/L),
and high (22.2 mmol/L) glucose concentrations on VSMC
growth. Glucose at different concentrations (except for low)
induced evident inhibition of VSMC proliferation vs control. Pro-
liferation activities are mean6SD of 10 measurements.
*P,0.001 vs CON. b, Effects of sorbitol at concentrations of 5.6,
14, and 22.2 mmol/L on VSMC growth. Sorbitol induced evident
inhibition of VSMC proliferation vs control. Proliferation activities
are mean6SD of 10 measurements. *P,0.001 vs CON.
Figure 2. a, Effects of increased concentrations of insulin (2, 20,
200 nmol/L) on VSMC growth. Insulin induced evident dose-
dependent increase of VSMC proliferation vs control. Effect is
significant even at low concentration of 2 nmol/L. Proliferation
activities are mean6SD of 10 measurements. #P,0.05 vs CON;
*P,0.001 vs CON. b, MAPK assays showing effect of insulin on
MAPK activation. Insulin increased MAPK activation, as demon-
strated by increase in ERK activation, at all concentrations. Only
at highest concentrations did insulin weakly activate JNK and
produce evident increase on P38 activation.
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STZ-induced diabetic rats without insulin therapy showed a
significant increase of plasma glucose levels (STZ group,
glycemia 428.3647.6 mg/dL, P,0.001 versus CON) and a
significant reduction of insulin blood levels (STZ group,
insulinemia 36.863.7 mU/mL, P,0.001 versus CON) (Fig-
ure 6). Insulin therapy reduced glycemia in the STZ1INS
group (glycemia 266.7618.2 mg/dL, P,0.001 versus STZ),
with a significant increase in insulin levels (insulinemia
136.869.1 mU/mL, P,0.01 versus CON) (Figure 6). Fur-
thermore, rats with transplants had a slight but significant
reduction of glycemia (Transp Hyperins group, glycemia
98.265 mg/dL, P,0.05 versus CON) and a significant
increase in blood insulin levels (Transp Hyperins group,
insulinemia 133.163.6 mU/mL, P,0.001 versus CON) (Fig-
ure 6). Finally, also in the STZ/INS/ras group, insulin therapy
reduced glycemia (glycemia 231.0616.2 mg/dL, P,0.001
versus STZ), with a significant increase in insulin level
(insulinemia 138.0614.6 mU/mL, P,0.01 versus CON)
(Figure 6).
Discussion
The major findings of the present study are that (1) hyper-
glycemia per se does not seem to be sufficient to induce an
increased neointimal formation after balloon injury, which in
hyperglycemic STZ-induced diabetic rats actually decreased;
and (2) hyperinsulinemia plays a major role in determining
the exaggerated neointimal hyperplasia after vascular injury
in rats; ERK downstream ras is the principal intracellular
target of the insulin actions on VSMCs.
Figure 3. a, Effects of glucose on VSMC migration vs FMLP.
Neither low nor high glucose concentrations affected VSMC
migration vs control and FMLP. Migration activities are
expressed as number of cells per high-power field (HPF) and
are mean6SD of 10 measurements. *P,0.01 vs all. b, Effects of
insulin (2, 200 nmol/L) on VSMC migration vs FMLP. Insulin
increased VSMC migration vs control and FMLP. Effect is signif-
icant even at low concentration of 2 nmol/L. Migration activities
are expressed as number of cells per HPF and are mean6SD of
10 measurements. *P,0.01 vs CON; #P,0.001 vs CON, FMLP.
Figure 4. a, Bars represent neointimal cross-sectional area of
common carotid arteries after balloon injury from rats subjected
to only balloon injury (CON), rats treated with STZ), insulin-
treated STZ-induced diabetic rats (STZ1INS), hyperinsulinemic
nondiabetic islet-transplanted rats (Transp Hyperins), and
insulin-treated rats with STZ-induced diabetes with transfection
of ras-negative mutant gene (STZ1INS/ras2). *P,0.001 vs CON;
#P,0.05 vs CON; †P,0.001 vs STZ1INS and Transp Hyperins.
b, Bars represent neointima/media ratio of common carotid
arteries after balloon injury from each group of animals studied.
*P,0.001 vs CON; †P,0.001 vs STZ1INS and Transp
Hyperins.
Figure 5. Representative hematoxylin-eosin–stained histological
sections of common carotid arteries after balloon injury from
each group of animals studied (abbreviations as in Figure 4).
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Role of Hyperglycemia on VSMCs In Vitro
and In Vivo
Although hyperglycemia may increase the expression of
several growth factors, such as platelet-derived growth factor,
and their effects on VSMC growth,12,19 our data demonstrated
that high glucose concentrations alone did not affect VSMC
migration and decreased VSMC proliferation in vitro (the 2
main mechanisms responsible for neointima formation after
balloon injury). Glucose effects were entirely nonspecific to
glucose metabolism as an inhibition of cell migration, and
proliferation was also obtained with an osmotically active
nonmetabolized agent, sorbitol. Therefore, we can simply
speculate that glucose effects on VSMC growth in vitro seem
to be related to an osmotic action.
Our in vivo data consistently demonstrated a significant
reduction in neointimal thickness after experimental angio-
plasty in hyperglycemic rats with STZ-induced diabetes,
although the glucose levels were ’400 to 500 mg/dL. Recent
data have also shown that in rabbits with alloxan-induced
diabetes, high glucose levels were associated with reduced
neointimal hyperplasia after balloon injury.20 This effect was
probably due to improved endothelial cell regrowth.20
Role of Hyperinsulinemia on VSMCs In Vitro
and on Neointimal Hyperplasia After Balloon
Injury In Vivo
High circulating insulin levels were associated with an
increased risk for coronary artery diseases.21,22 It has also
been hypothesized, but never proved, that hyperinsulinemia
in non–insulin-dependent diabetes mellitus (NIDDM) exerts
a detrimental effect on injured vessels and underlies the high
mortality in diabetic patients23 after percutaneous translumi-
nal coronary angioplasty. Likewise, hyperinsulinemia in non-
diabetic patients seems to be a good predictor of restenosis
after coronary stenting.24 Furthermore, it has also been
suggested that increased levels of plasminogen activator
inhibitor type 1 secondary to high insulin levels are likely to
mediate the adverse effects of insulin on vessel wall.25 The
BARI trial showed an increased mortality only in patients
who were treated with oral hypoglycemic agents or insulin.1
These observations imply that higher insulin levels in these
patients underlie the adverse outcome after angioplasty.1
Moreover, atherosclerosis-like lesions were documented
when long-term insulin injections were performed in rats.26 In
addition, the intensive treatment of diabetes with insulin was
not associated with a reduction in the occurrence of coronary
artery disease in either the DCCT trial27 or the UKPDS
Study.28
In many NIDDM patients, insulin levels are higher than
those in nondiabetic subjects.23 In the presence of insulin
resistance, when the metabolic action of insulin is ineffective,
the proliferative response to hyperinsulinemia may still
occur.23
In IDDM, insulin therapy is delivered in nonphysiological
ways with respect to route and control of delivery. Thus, in
many patients with IDDM, tissues may be exposed to higher
levels of insulin than in those without diabetes.
VSMC migration and proliferation play a major role in the
pathogenesis of restenosis in diabetic patients. Our data
demonstrated that insulin increases VSMC migration and
proliferation. The primary physiological substrate of the
insulin receptor tyrosine kinase is a protein called insulin
receptor substrate-1 (IRS-1). IRS-1 is associated with the
adaptor protein GRB-2, which links IRS-1 to the ras-raf-
MAPK cascade, which is the central pathway for VSMC
growth. Insulin increases the amount of farnesylated p21ras
in VSMCs.29 Furthermore, recent data demonstrated in-
creased amounts of farnesylated p21ras in tissues of hyper-
insulinemic animals.29 Finally, our laboratory previously
demonstrated that the inhibition of ras or MAPK genes
prevented neointimal formation after balloon angioplasty in
rats.16,18,30,31
The role of hyperinsulinemia in promoting restenosis,
however, is still a controversial issue.32–34 The diabetic state
affects different stages of the restenotic process.32 In fact, it
has been suggested that many of the potential mechanisms
promoting restenosis in diabetic patients correlate with hy-
perglycemia rather than hyperinsulinemia.32,33
A recent study demonstrated an association between
MAPK activity and VSMC proliferation after vascular injury
in diabetic rabbits independent of insulin-like growth factor-
1.35 In agreement with these data, we have demonstrated that
insulin increased MAPK activation; furthermore, we have
also shown that ERK downstream ras is the principal intra-
cellular target of the insulin actions on VSMCs. Nevertheless,
it should be pointed out that the insulin concentrations used in
our study were clearly much higher than those encountered in
vivo, but this is not surprising, because such high concentra-
Figure 6. a, Bars represent plasma glucose levels from each
group of animals studied. Abbreviations as in Figure 4.
*P,0.001 vs CON; #P,0.01 vs STZ; †P,0.05 vs CON;
‡P,0.01 vs CON. b, Bars represent insulin levels from each
group of animals studied. *P,0.001 vs CON; #P,0.001 vs all.
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tions are required in view of the known differences between
rodents and humans.
Our in vivo data demonstrated that insulin therapy in
diabetic rats reduced plasma glucose levels at the expense of
a significant increase in insulin blood levels. This increase in
insulin blood levels was associated with the exaggerated
neointimal hyperplasia observed after balloon injury.
To increase the insulin levels in nondiabetic rats and to
obtain a model of hyperinsulinemia as the only risk factor for
exaggerated neointimal hyperplasia, we performed an addi-
tional protocol in which pancreatic islets were transplanted in
normal nondiabetic animals under the kidney capsule.14 In
this group, we observed an increase of insulin blood levels
similar to that in STZ-induced diabetic rats with insulin
therapy. In these animals, we also observed an exaggerated
neointimal formation after experimental balloon angioplasty.
Finally, in hyperinsulinemic STZ-induced diabetic rats, the
transfection of a ras-negative mutant gene reduced neointi-
mal hyperplasia after balloon injury.
Taken together, these data further support the hypothesis
that hyperinsulinemia, by increasing ras/MAPK pathway
activation, is the main mechanism responsible for the greater
rate of restenosis observed in diabetic patients.
Animal Models and Limitations of the Study
STZ administered to mature rats induces severe and perma-
nent diabetes, with a decrease in insulin levels, to produce a
cytotoxic model of diabetes very similar to IDDM.13
To further rule out a possible acute effect of STZ per se on
VSMC proliferation in vivo, we also performed experiments
in rats that had been rendered diabetic by STZ in the neonatal
period (3 days after birth). In this same group of hypergly-
cemic and insulinopenic animals, the injury was performed at
14 weeks after birth, and we observed the same effects of
balloon injury on neointimal hyperplasia as in the adult model
of STZ-induced diabetes (data not shown).
Clinical adverse experience in subjects with diabetes un-
dergoing coronary interventions is encountered predomi-
nantly in patients with type 2 diabetes because of the much
higher prevalence of type 2 (accounting for .90% of diabetic
patients) than type 1 diabetes. For this reason, caution should
be used in extrapolating the present results in a clinical
setting. Because of the greater duration of the disease,
however, patients with IDDM risk higher cardiovascular
morbidity and mortality than those with NIDDM. Further-
more, because of their insulin-requiring state, IDDM patients
are exposed for a longer period to the potentially detrimental
effects of insulin.
To obtain a rat model of hyperinsulinemia without diabe-
tes, we used a standard technique to transplant pancreatic
islets under the kidney capsule in nondiabetic rats.14 This
allowed us to have hyperinsulinemia as a single potential
factor promoting neointimal hyperplasia after balloon
angioplasty.
Finally, in the present study, the blood samples to assess
glucose and insulin levels were obtained in anesthetized
animals. It is likely that slightly different results could be
obtained in conscious animals.
Clinical Relevance of the Study
Our experimental data support the hypothesis that rigorous
glycemic control alone may not be sufficient to reduce the
rate of restenosis in diabetic patients. Rather, hyperinsulin-
emia is responsible for the exaggerated neointimal prolifera-
tion observed in our animal models and could explain the
increased restenosis rate observed after interventional proce-
dures in diabetic patients. Therefore, it should be pointed out
that in diabetic patients who require insulin therapy, good
control of blood glucose should be obtained with the lowest
possible levels of circulating insulin.
Further clinical trials are needed, however, to evaluate the
impact of both hyperinsulinemia and tight glycemic control
on the rate of restenosis after balloon angioplasty and
coronary stenting in diabetic patients.
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